Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks
McKesson (MCK) fell 9.1% post-earnings despite a solid quarter. AdaptHealth (AHCO) missed revenue and EBITDA estimates, down 46.2%. Elevance Health (ELV) beat revenue and EPS estimates but lost customers, down 7.4%. Quest (DGX) topped expectations, up 12.6%.
How this was made
The 30-second read
Why it matters
Earnings releases cause varied price moves, highlighting sector rotation.
Market read
Earnings-driven price swings provide short‑term trading opportunities across the healthcare services space.
What to watch
Member loss at ELV may be temporary; AHCO's revenue growth still outpaces peers.
Background
Quarterly earnings season for healthcare providers and services.
Ticker impact
Q2 earnings released; stock down 9.1% since report.
Potential further downside if guidance remains weak.
Revenue and earnings fell short of expectations, prompting a 9% drop.
Q2 earnings released; stock down 46.2% since report.
Likely continued pressure unless guidance improves.
Revenue up 12.7% YoY but missed estimates; full‑year guidance also missed, driving a large decline.
Q2 earnings released; stock down 7.4% since report.
Modest further downside expected.
Revenue flat, slight EPS beat, but member loss signals weaker future growth.
Q2 earnings released; stock up 12.6% since report.
Potential upside continuation if guidance stays strong.
Revenue up 10.2% YoY and beat estimates, leading to a double‑digit gain.
Market effects
Healthcare services sector shows divergent performance across peers.
U.S. healthcare stocks may see broader volatility.
Limited to U.S. markets; no direct global macro link.
Counterpoint
Despite broad sector weakness, DGX's strong beat could signal a buying opportunity.
Key entities
- companyMcKesson
Healthcare distribution giant.
- companyAdaptHealth
Home medical equipment provider.
- companyElevance Health
Health insurer.
- companyQuest Diagnostics
Diagnostic testing services.
